share_log

HC Wainwright & Co. Reiterates Buy on Opus Genetics, Maintains $8 Price Target

HC Wainwright & Co. Reiterates Buy on Opus Genetics, Maintains $8 Price Target

HC Wainwright & Co. 重申对Opus Genetics的买入评级,维持8美元的价格目标
Benzinga ·  12/12 19:29  · 评级/大行评级

HC Wainwright & Co. analyst Matthew Caufield reiterates Opus Genetics (NASDAQ:IRD) with a Buy and maintains $8 price target.

HC Wainwright & Co. 分析师Matthew Caufield 重申对Opus Genetics (纳斯达克:IRD)的买入评级,并维持目标价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发